Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor (Q24338711)

GOA release 2020-03-11

1 reference

7

Akiyoshi Fukamizu

0 references

author name string

WuQiang Fan

1

0 references

Toshihiko Yanase

2

0 references

Hidetaka Morinaga

3

0 references

Taijiro Okabe

4

0 references

Masatoshi Nomura

5

0 references

Hiroaki Daitoku

6

0 references

Shigeaki Kato

8

0 references

Ryoichi Takayanagi

9

0 references

Hajime Nawata

Journal of Biological Chemistry

10

0 references

language of work or name

English

0 references

publication date

9 March 2007

0 references

published in

0 references

volume

282

0 references

issue

10

0 references

page(s)

7329-38

0 references

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

The androgen receptor: a potential target for therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Contribution of the androgen receptor to prostate cancer predisposition and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Androgen receptor signaling in androgen-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Insulin-like growth factors and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Relationship between obesity and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Insulin resistance and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Protein kinase A potentiates adrenal 4 binding protein/steroidogenic factor 1 transactivation by reintegrating the subcellular dynamic interactions of the nuclear receptor with its cofactors, general control nonderepressed-5/transformation/transcrip

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Nuclear compartmentalization of N-CoR and its interactions with steroid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Insulin-like growth factors and neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Re: Insulin resistance and prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Rapid signalling pathway activation by androgens in epithelial and stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Testicular zinc finger protein recruits histone deacetylase 2 and suppresses the transactivation function and intranuclear foci formation of agonist-bound androgen receptor competitively with TIF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

Androgens negatively regulate forkhead transcription factor FKHR (FOXO1) through a proteolytic mechanism in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M610447200

21 January 2018

Identifiers

DOI

10.1074/JBC.M610447200

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17202144

1 reference

Consolidated OpenCitations Corpus – April 2017